UNRESECTABLE LUNG NON-SMALL CELL CARCINOMA
Clinical trials for UNRESECTABLE LUNG NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE LUNG NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE LUNG NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mayo clinic tests higher radiation dose to control tough lung cancers
Disease control CompletedThis study tested whether a higher dose of proton beam radiation works better than a standard dose when combined with chemotherapy for patients with inoperable stage 2 or 3 non-small cell lung cancer. Twenty patients were randomly assigned to receive either 60 Gy or 72 Gy of prot…
Matched conditions: UNRESECTABLE LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Scientists test Triple-Threat combo to supercharge immune system against lung cancer
Disease control CompletedThis early-stage trial tested the safety of combining radiation therapy with one or two new immunotherapy drugs for patients with a specific type of advanced lung cancer. The study involved 26 adults whose cancer had spread locally but not to distant organs and who had high level…
Matched conditions: UNRESECTABLE LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Virtual therapy trial aims to boost strength and spirits during lung cancer fight
Symptom relief CompletedThis study tested whether a 12-week virtual support program could help older adults with advanced lung cancer feel better physically and emotionally during their cancer treatment. One hundred participants were randomly assigned to either receive the program—which included guided …
Matched conditions: UNRESECTABLE LUNG NON-SMALL CELL CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Mar 20, 2026 14:58 UTC